Stephen Beverley, PhD, a professor of molecular microbiology at Washington University School of Medicine in St. Louis, has been named an American Society for Microbiology Distinguished Lecturer. He is one of eight scientists chosen in recognition of their outstanding contributions to the field of microbiology, proven ability to give clear and compelling talks, and interest in working with students and other early-career scientists.
As a distinguished lecturer, Beverley will speak at microbiology meetings throughout the U.S. at the request of local branches of the American Society for Microbiology. His visits will provide opportunities for students, postdoctoral researchers and junior faculty to interact with and learn from a leader in the field. He will serve in the position for two years.
Beverley studies the deadly protozoan parasite Leishmania, which is spread by the bite of a sand fly and infects 100 million people worldwide every year. His work helped delineate the complicated Leishmania life cycle, and his studies of the molecular genetics of the protozoan have led to new targets for drug treatment and a better understanding of how the parasite evades the immune system. Beverley also has pioneered the use of genetically modified parasites as safe live vaccines and drug-delivery tools.